The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vincristine     Quarter: 2016Q3

Total Records: 1,179     Number of Pages: 59

DRUGNAME PT EventCount
VINCRISTINE Renal tubular disorder 5
Vincristine Transaminases increased 5
VINCRISTINE Viral load increased 5
VINCRISTINE (manufacturer unknown) Hepatitis B 5
VINCRISTINE SULFATE. Blood culture positive 5
VINCRISTINE SULFATE. Body temperature increased 5
VINCRISTINE SULFATE. Colitis 5
VINCRISTINE SULFATE. Drug ineffective 5
VINCRISTINE SULFATE. Encephalopathy 5
VINCRISTINE SULFATE. Escherichia sepsis 5
VINCRISTINE SULFATE. Headache 5
VINCRISTINE SULFATE. Hepatic ischaemia 5
VINCRISTINE SULFATE. Hepatomegaly 5
VINCRISTINE SULFATE. Mucosal inflammation 5
VINCRISTINE SULFATE. Neoplasm progression 5
VINCRISTINE SULFATE. Neuropathy peripheral 5
VINCRISTINE SULFATE. Oral pain 5
VINCRISTINE SULFATE. Polyneuropathy 5
VINCRISTINE SULFATE. Respiratory distress 5
VINCRISTINE SULFATE. Respiratory failure 5

Total Records: 1,179     Number of Pages: 59